Novo Nordisk Pharma (Thailand) Ltd.

Industry and Activities

Pharmaceutical

Senior Management

  1. Enrico Cañal Bruland, Vice President & General Manager (Thailand)
  2. Jimi Kehlet, Financial & Operations Director
  3. Vera Bakirova, People & Organization Director
  4. Gurudutt Nayak, CMRQ Director
  5. Nattha Srisomwong, Legal & Compliance Director
  6. Yuwadee Chiratiticharoen, Commercial BU Director – Obesity
  7. Nattaporn Huajaikaew, Commercial BU Director – Insulin
  8. Ticha Chookham, Commercial BU Director – GLP-1
  9. Selina Christodoulakis, Commercial BU Director - Rare Disease & Patient Access Director
  10. Itthipon Lalitthamsiri , Director of Customer Engagement

Contact Information
Address:
98, Sathorn Square Office Tower, Unit 2101-2105 21st Floor, North Sathorn Road, Silom Bangrak District, Bangkok 10500 Thailand
Phone Number:
+66 2 237 9263
Products and Services

We have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens. Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. We make long-term investments in novel treatments and technologies, including curative stem cell based therapies, to continually advance the development of medical devices and digital health solutions. Providing treatment for five diseases.

1. Diabetes Type 1
2. Diabetes Type 2
3. Obesity
4. Haemophilia
5. Growth Disorders

EABC Representative

Name:
Enrico Cañal Bruland

Position:
Vice President & General Manager (Thailand)

Contact information for member only.

Company Profile

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 47,000 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com,
Facebook, Twitter, LinkedIn and YouTube.